Simultaneously measuring levels of two blood proteins — glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) — may offer a clearer way to track both disease activity and disability progression in people with multiple sclerosis (MS), according to a new long-term study. Each marker is tied to a different clinical outcome: NfL helps […]
The post Two-protein blood test may better track MS activity, disability appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com